Other
Drugs in sport: can science stop the cheats?
- The World Anti-Doping Agency (WADA) faces a structural disadvantage as a "naked legislator" that creates rules it lacks the capacity to enforce.
- International Olympic Committee (IOC) resistance and a desire for control have historically hindered the development of a robust independent anti-doping institution.
- Since the IOC began testing in 1968, doping detection has evolved from simple chemical identification to complex biological monitoring.
- The introduction of the Athlete Biological Passport in 2009 aimed to detect blood composition changes rather than specific substances, resulting in over 200 caught athletes.
- Despite the Passport system, only 1–2% of tests remain positive, suggesting a massive gap between detected and actual doping prevalence.
- An anonymous survey at the 2011 World Athletics Championships revealed that 44% of athletes admitted to doping in the past year, contrasting sharply with official detection rates.
- British Paralympian Ali Jawad estimates that the current system misses 30–40% of doping cases, with many athletes missing out on medals due to undetected cheaters.
- Doping methods have shifted from basic animal steroids to sophisticated human growth hormones and blood doping involving EPO.
- New detection challenges arise from daily innovations in drug design and the creation of untested drug cocktails.
- A biobank introduced in 2004 enables the retesting of athlete samples over an eight-year period, allowing for the detection of doping years after the event.
- In 2011, two Russian whistleblowers and intelligence sources were critical in uncovering doping cases that might otherwise have remained hidden.
- Dr. Yanis Pitsiladis of the IOC Medical and Scientific Commission is developing a genetic sequencing method to detect blood doping by identifying changes in up to 21,000 genes.
- The new genetic approach tracks biomarkers that switch on or off after drug intake, capable of detecting doping weeks or months later.
- This advanced genetic testing faces significant barriers, including an estimated cost of £4 million and the need for supercomputers and DNA sequencers.
- Dr. Pitsiladis has secured over £500,000 in funding from WADA and private sponsors but remains frustrated by the broader funding gap in anti-doping research.
- Chinese companies have agreed to lend sequencing equipment, yet the scarcity of resources remains a typical challenge for anti-doping scientists.
- Marion Jones has publicly admitted to using steroids, while Lance Armstrong received a lifetime ban from UCI Cycling.
- Advances in science allow athletes to dope more easily even as detection capabilities improve, maintaining a perpetual "catch-up" dynamic.
- Current anti-doping efforts rely heavily on manipulating or hiding biological markers, which allows many sophisticated doping regimens to evade standard testing.